Report cover image

Global Animal Anti Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 187 Pages
SKU # APRC20553105

Description

Summary

According to APO Research, The global Animal Anti Rabies Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Animal Anti Rabies Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Animal Anti Rabies Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Animal Anti Rabies Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Animal Anti Rabies Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Animal Anti Rabies Vaccine include Boehringer Ingelheim, Cadila Pharmaceuticals, Serum Institute of India, Yisheng Group, GSK, Liaoning Chengda, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Animal Anti Rabies Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Animal Anti Rabies Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Animal Anti Rabies Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Anti Rabies Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Animal Anti Rabies Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Animal Anti Rabies Vaccine sales, projected growth trends, production technology, application and end-user industry.

Animal Anti Rabies Vaccine Segment by Company

Boehringer Ingelheim
Cadila Pharmaceuticals
Serum Institute of India
Yisheng Group
GSK
Liaoning Chengda
Merck
Sanofi
Animal Anti Rabies Vaccine Segment by Type

Baby Hamster Kidney (BHK) Rabies Vaccine
Chick Embryo Cell Rabies Vaccine
Vero Cell Rabies Vaccine
Other
Animal Anti Rabies Vaccine Segment by Application

Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Animal Anti Rabies Vaccine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Anti Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Anti Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Anti Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Anti Rabies Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Anti Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Anti Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Animal Anti Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

187 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Animal Anti Rabies Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Animal Anti Rabies Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Animal Anti Rabies Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Animal Anti Rabies Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Animal Anti Rabies Vaccine Market Dynamics
2.1 Animal Anti Rabies Vaccine Industry Trends
2.2 Animal Anti Rabies Vaccine Industry Drivers
2.3 Animal Anti Rabies Vaccine Industry Opportunities and Challenges
2.4 Animal Anti Rabies Vaccine Industry Restraints
3 Animal Anti Rabies Vaccine Market by Manufacturers
3.1 Global Animal Anti Rabies Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Animal Anti Rabies Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Animal Anti Rabies Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Animal Anti Rabies Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Animal Anti Rabies Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Animal Anti Rabies Vaccine Manufacturers, Product Type & Application
3.7 Global Animal Anti Rabies Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Animal Anti Rabies Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Animal Anti Rabies Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Animal Anti Rabies Vaccine Tier 1, Tier 2, and Tier 3
4 Animal Anti Rabies Vaccine Market by Type
4.1 Animal Anti Rabies Vaccine Type Introduction
4.1.1 Baby Hamster Kidney (BHK) Rabies Vaccine
4.1.2 Chick Embryo Cell Rabies Vaccine
4.1.3 Vero Cell Rabies Vaccine
4.1.4 Other
4.2 Global Animal Anti Rabies Vaccine Sales by Type
4.2.1 Global Animal Anti Rabies Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Animal Anti Rabies Vaccine Sales by Type (2020-2031)
4.2.3 Global Animal Anti Rabies Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Animal Anti Rabies Vaccine Revenue by Type
4.3.1 Global Animal Anti Rabies Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Animal Anti Rabies Vaccine Revenue by Type (2020-2031)
4.3.3 Global Animal Anti Rabies Vaccine Revenue Market Share by Type (2020-2031)
5 Animal Anti Rabies Vaccine Market by Application
5.1 Animal Anti Rabies Vaccine Application Introduction
5.1.1 Pre-exposure Prophylaxis
5.1.2 Post-exposure Prophylaxis
5.2 Global Animal Anti Rabies Vaccine Sales by Application
5.2.1 Global Animal Anti Rabies Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Animal Anti Rabies Vaccine Sales by Application (2020-2031)
5.2.3 Global Animal Anti Rabies Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Animal Anti Rabies Vaccine Revenue by Application
5.3.1 Global Animal Anti Rabies Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Animal Anti Rabies Vaccine Revenue by Application (2020-2031)
5.3.3 Global Animal Anti Rabies Vaccine Revenue Market Share by Application (2020-2031)
6 Global Animal Anti Rabies Vaccine Sales by Region
6.1 Global Animal Anti Rabies Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Animal Anti Rabies Vaccine Sales by Region (2020-2031)
6.2.1 Global Animal Anti Rabies Vaccine Sales by Region (2020-2025)
6.2.2 Global Animal Anti Rabies Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Animal Anti Rabies Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Animal Anti Rabies Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Animal Anti Rabies Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Animal Anti Rabies Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Animal Anti Rabies Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Animal Anti Rabies Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Animal Anti Rabies Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Animal Anti Rabies Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Animal Anti Rabies Vaccine Revenue by Region
7.1 Global Animal Anti Rabies Vaccine Revenue by Region
7.1.1 Global Animal Anti Rabies Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Animal Anti Rabies Vaccine Revenue by Region (2020-2025)
7.1.3 Global Animal Anti Rabies Vaccine Revenue by Region (2026-2031)
7.1.4 Global Animal Anti Rabies Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Animal Anti Rabies Vaccine Revenue (2020-2031)
7.2.2 North America Animal Anti Rabies Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Animal Anti Rabies Vaccine Revenue (2020-2031)
7.3.2 Europe Animal Anti Rabies Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Animal Anti Rabies Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Animal Anti Rabies Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Animal Anti Rabies Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Animal Anti Rabies Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Comapny Information
8.1.2 Boehringer Ingelheim Business Overview
8.1.3 Boehringer Ingelheim Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Boehringer Ingelheim Animal Anti Rabies Vaccine Product Portfolio
8.1.5 Boehringer Ingelheim Recent Developments
8.2 Cadila Pharmaceuticals
8.2.1 Cadila Pharmaceuticals Comapny Information
8.2.2 Cadila Pharmaceuticals Business Overview
8.2.3 Cadila Pharmaceuticals Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Cadila Pharmaceuticals Animal Anti Rabies Vaccine Product Portfolio
8.2.5 Cadila Pharmaceuticals Recent Developments
8.3 Serum Institute of India
8.3.1 Serum Institute of India Comapny Information
8.3.2 Serum Institute of India Business Overview
8.3.3 Serum Institute of India Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Serum Institute of India Animal Anti Rabies Vaccine Product Portfolio
8.3.5 Serum Institute of India Recent Developments
8.4 Yisheng Group
8.4.1 Yisheng Group Comapny Information
8.4.2 Yisheng Group Business Overview
8.4.3 Yisheng Group Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Yisheng Group Animal Anti Rabies Vaccine Product Portfolio
8.4.5 Yisheng Group Recent Developments
8.5 GSK
8.5.1 GSK Comapny Information
8.5.2 GSK Business Overview
8.5.3 GSK Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 GSK Animal Anti Rabies Vaccine Product Portfolio
8.5.5 GSK Recent Developments
8.6 Liaoning Chengda
8.6.1 Liaoning Chengda Comapny Information
8.6.2 Liaoning Chengda Business Overview
8.6.3 Liaoning Chengda Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Liaoning Chengda Animal Anti Rabies Vaccine Product Portfolio
8.6.5 Liaoning Chengda Recent Developments
8.7 Merck
8.7.1 Merck Comapny Information
8.7.2 Merck Business Overview
8.7.3 Merck Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Merck Animal Anti Rabies Vaccine Product Portfolio
8.7.5 Merck Recent Developments
8.8 Sanofi
8.8.1 Sanofi Comapny Information
8.8.2 Sanofi Business Overview
8.8.3 Sanofi Animal Anti Rabies Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Sanofi Animal Anti Rabies Vaccine Product Portfolio
8.8.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Animal Anti Rabies Vaccine Value Chain Analysis
9.1.1 Animal Anti Rabies Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Animal Anti Rabies Vaccine Production Mode & Process
9.2 Animal Anti Rabies Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Animal Anti Rabies Vaccine Distributors
9.2.3 Animal Anti Rabies Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.